$RTRX Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in Travere Therapeutics, Inc..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in Travere Therapeutics, Inc.. Get notifications about new insider transactions in Travere Therapeutics, Inc. for free.
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
May 13 2020 | RTRX | Retrophin, Inc. | ROTE WILLIAM E. | Senior Vice Preside ... | Sell | S | 16.98 | 527 | 8,951 | 23,494 | 24 K to 23.5 K (-2.19 %) |
May 13 2020 | RTRX | Retrophin, Inc. | ROTE WILLIAM E. | Senior Vice Preside ... | Sell | S | 17.16 | 812 | 13,934 | 24,021 | 24.8 K to 24 K (-3.27 %) |
May 13 2020 | RTRX | Retrophin, Inc. | ROTE WILLIAM E. | Senior Vice Preside ... | Sell | S | 14.95 | 813 | 12,154 | 24,833 | 25.6 K to 24.8 K (-3.17 %) |
May 13 2020 | RTRX | Retrophin, Inc. | Clague Laura | Chief Financial Off ... | Sell | S | 16.98 | 527 | 8,951 | 19,473 | 20 K to 19.5 K (-2.63 %) |
May 13 2020 | RTRX | Retrophin, Inc. | Clague Laura | Chief Financial Off ... | Sell | S | 17.16 | 1,250 | 21,450 | 20,000 | 21.3 K to 20 K (-5.88 %) |
May 13 2020 | RTRX | Retrophin, Inc. | Clague Laura | Chief Financial Off ... | Sell | S | 14.95 | 1,250 | 18,688 | 21,250 | 22.5 K to 21.3 K (-5.56 %) |
May 13 2020 | RTRX | Retrophin, Inc. | Rosenberg Noah L. | Chief Medical Offic ... | Sell | S | 16.98 | 527 | 8,951 | 26,728 | 27.3 K to 26.7 K (-1.93 %) |
May 13 2020 | RTRX | Retrophin, Inc. | REED ELIZABETH E | SVP, GC & Corporate ... | Sell | S | 16.98 | 527 | 8,951 | 25,431 | 26 K to 25.4 K (-2.03 %) |
May 13 2020 | RTRX | Retrophin, Inc. | REED ELIZABETH E | SVP, GC & Corporate ... | Sell | S | 17.16 | 525 | 9,009 | 25,958 | 26.5 K to 26 K (-1.98 %) |
May 13 2020 | RTRX | Retrophin, Inc. | REED ELIZABETH E | SVP, GC & Corporate ... | Sell | S | 14.95 | 525 | 7,849 | 26,483 | 27 K to 26.5 K (-1.94 %) |
May 13 2020 | RTRX | Retrophin, Inc. | ROTE WILLIAM E. | Senior Vice Preside ... | Sell | S | 16.98 | 527 | 8,951 | 23,494 | 24 K to 23.5 K (-2.19 %) |
May 13 2020 | RTRX | Retrophin, Inc. | ROTE WILLIAM E. | Senior Vice Preside ... | Sell | S | 17.16 | 812 | 13,934 | 24,021 | 24.8 K to 24 K (-3.27 %) |
May 13 2020 | RTRX | Retrophin, Inc. | ROTE WILLIAM E. | Senior Vice Preside ... | Sell | S | 14.95 | 813 | 12,154 | 24,833 | 25.6 K to 24.8 K (-3.17 %) |
May 13 2020 | RTRX | Retrophin, Inc. | Clague Laura | Chief Financial Off ... | Sell | S | 16.98 | 527 | 8,951 | 19,473 | 20 K to 19.5 K (-2.63 %) |
May 13 2020 | RTRX | Retrophin, Inc. | Clague Laura | Chief Financial Off ... | Sell | S | 17.16 | 1,250 | 21,450 | 20,000 | 21.3 K to 20 K (-5.88 %) |
May 13 2020 | RTRX | Retrophin, Inc. | Clague Laura | Chief Financial Off ... | Sell | S | 14.95 | 1,250 | 18,688 | 21,250 | 22.5 K to 21.3 K (-5.56 %) |
May 13 2020 | RTRX | Retrophin, Inc. | Rosenberg Noah L. | Chief Medical Offic ... | Sell | S | 16.98 | 527 | 8,951 | 26,728 | 27.3 K to 26.7 K (-1.93 %) |
May 06 2020 | RTRX | Retrophin, Inc. | ASELAGE STEVE | Director | Sell | S | 15.88 | 2,500 | 39,700 | 253,857 | 256.4 K to 253.9 K (-0.98 %) |
Apr 09 2020 | RTRX | Retrophin, Inc. | Bruhn Suzanne Louise | Director | Option Exercise | A | 15.63 | 15,750 | 246,173 | 15,750 | |
Apr 09 2020 | RTRX | Retrophin, Inc. | Bruhn Suzanne Louise | Director | Grant | A | 0.00 | 5,250 | 0 | 5,250 | 0 to 5.3 K |
Apr 09 2020 | RTRX | Retrophin, Inc. | Bruhn Suzanne Louise | Director | Option Exercise | A | 15.63 | 15,750 | 246,173 | 15,750 | |
Apr 09 2020 | RTRX | Retrophin, Inc. | Bruhn Suzanne Louise | Director | Grant | A | 0.00 | 5,250 | 0 | 5,250 | 0 to 5.3 K |
Mar 12 2020 | RTRX | Retrophin, Inc. | ROTE WILLIAM E. | Senior Vice Preside ... | Sell | S | 14.87 | 3,250 | 48,328 | 25,646 | 28.9 K to 25.6 K (-11.25 %) |
Mar 12 2020 | RTRX | Retrophin, Inc. | REED ELIZABETH E | SVP, GC & Corporate ... | Sell | S | 15.02 | 3,500 | 52,570 | 27,008 | 30.5 K to 27 K (-11.47 %) |
Mar 12 2020 | RTRX | Retrophin, Inc. | Clague Laura | Chief Financial Off ... | Sell | S | 15.02 | 4,000 | 60,080 | 22,500 | 26.5 K to 22.5 K (-15.09 %) |
Mar 09 2020 | RTRX | Retrophin, Inc. | ROTE WILLIAM E. | Senior Vice Preside ... | Grant | A | 0.00 | 3,250 | 0 | 28,896 | 25.6 K to 28.9 K (+12.67 %) |
Mar 09 2020 | RTRX | Retrophin, Inc. | REED ELIZABETH E | SVP, GC & Corporate ... | Grant | A | 0.00 | 3,500 | 0 | 30,508 | 27 K to 30.5 K (+12.96 %) |
Mar 09 2020 | RTRX | Retrophin, Inc. | Clague Laura | Chief Financial Off ... | Grant | A | 0.00 | 4,000 | 0 | 26,500 | 22.5 K to 26.5 K (+17.78 %) |
Mar 09 2020 | RTRX | Retrophin, Inc. | Rosenberg Noah L. | Chief Medical Offic ... | Sell | S | 15.36 | 1,790 | 27,487 | 27,255 | 29 K to 27.3 K (-6.16 %) |
Mar 09 2020 | RTRX | Retrophin, Inc. | Rosenberg Noah L. | Chief Medical Offic ... | Grant | A | 0.00 | 5,000 | 0 | 29,045 | 24 K to 29 K (+20.79 %) |
Mar 09 2020 | RTRX | Retrophin, Inc. | ASELAGE STEVE | Director | Sell | S | 15.36 | 4,359 | 66,939 | 256,357 | 260.7 K to 256.4 K (-1.67 %) |
Mar 09 2020 | RTRX | Retrophin, Inc. | ASELAGE STEVE | Director | Grant | A | 0.00 | 12,250 | 0 | 260,716 | 248.5 K to 260.7 K (+4.93 %) |
Feb 19 2020 | RTRX | Retrophin, Inc. | ROTE WILLIAM E. | Senior Vice Preside ... | Sell | S | 16.55 | 1,250 | 20,688 | 25,646 | 26.9 K to 25.6 K (-4.65 %) |
Feb 19 2020 | RTRX | Retrophin, Inc. | ROTE WILLIAM E. | Senior Vice Preside ... | Sell | S | 16.72 | 1,250 | 20,900 | 26,896 | 28.1 K to 26.9 K (-4.44 %) |
Feb 07 2020 | RTRX | Retrophin, Inc. | ASELAGE STEVE | Director | Sell | S | 16.62 | 2,500 | 41,550 | 248,466 | 251 K to 248.5 K (-1.00 %) |
Jan 31 2020 | RTRX | Retrophin, Inc. | ROTE WILLIAM E. | Senior Vice Preside ... | Option Exercise | A | 0.00 | 10,000 | 0 | 10,000 | |
Jan 31 2020 | RTRX | Retrophin, Inc. | ROTE WILLIAM E. | Senior Vice Preside ... | Option Exercise | A | 0.00 | 9,000 | 0 | 9,000 | |
Jan 31 2020 | RTRX | Retrophin, Inc. | ROTE WILLIAM E. | Senior Vice Preside ... | Option Exercise | A | 15.46 | 55,000 | 850,300 | 55,000 | |
Jan 31 2020 | RTRX | Retrophin, Inc. | ROTE WILLIAM E. | Senior Vice Preside ... | Grant | A | 0.00 | 9,000 | 0 | 27,185 | 18.2 K to 27.2 K (+49.49 %) |
Jan 31 2020 | RTRX | Retrophin, Inc. | Rosenberg Noah L. | Chief Medical Offic ... | Option Exercise | A | 0.00 | 10,000 | 0 | 10,000 | |
Jan 31 2020 | RTRX | Retrophin, Inc. | Rosenberg Noah L. | Chief Medical Offic ... | Option Exercise | A | 0.00 | 9,000 | 0 | 9,000 | |
Jan 31 2020 | RTRX | Retrophin, Inc. | Rosenberg Noah L. | Chief Medical Offic ... | Option Exercise | A | 15.46 | 55,000 | 850,300 | 55,000 | |
Jan 31 2020 | RTRX | Retrophin, Inc. | Rosenberg Noah L. | Chief Medical Offic ... | Grant | A | 0.00 | 9,000 | 0 | 22,500 | 13.5 K to 22.5 K (+66.67 %) |
Jan 31 2020 | RTRX | Retrophin, Inc. | REED ELIZABETH E | SVP, GC & Corporate ... | Option Exercise | A | 0.00 | 10,000 | 0 | 10,000 | |
Jan 31 2020 | RTRX | Retrophin, Inc. | REED ELIZABETH E | SVP, GC & Corporate ... | Option Exercise | A | 0.00 | 9,000 | 0 | 9,000 | |
Jan 31 2020 | RTRX | Retrophin, Inc. | REED ELIZABETH E | SVP, GC & Corporate ... | Option Exercise | A | 15.46 | 55,000 | 850,300 | 55,000 | |
Jan 31 2020 | RTRX | Retrophin, Inc. | REED ELIZABETH E | SVP, GC & Corporate ... | Grant | A | 0.00 | 9,000 | 0 | 27,008 | 18 K to 27 K (+49.98 %) |
Jan 31 2020 | RTRX | Retrophin, Inc. | Heerma Peter | Chief Commercial Of ... | Option Exercise | A | 0.00 | 9,000 | 0 | 9,000 | |
Jan 31 2020 | RTRX | Retrophin, Inc. | Heerma Peter | Chief Commercial Of ... | Option Exercise | A | 15.46 | 55,000 | 850,300 | 55,000 | |
Jan 31 2020 | RTRX | Retrophin, Inc. | Heerma Peter | Chief Commercial Of ... | Grant | A | 0.00 | 9,000 | 0 | 44,000 | 35 K to 44 K (+25.71 %) |
Jan 31 2020 | RTRX | Retrophin, Inc. | Clague Laura | Chief Financial Off ... | Option Exercise | A | 0.00 | 10,000 | 0 | 10,000 | |
Jan 31 2020 | RTRX | Retrophin, Inc. | Clague Laura | Chief Financial Off ... | Option Exercise | A | 0.00 | 9,000 | 0 | 9,000 | |
Jan 31 2020 | RTRX | Retrophin, Inc. | Clague Laura | Chief Financial Off ... | Option Exercise | A | 15.46 | 55,000 | 850,300 | 55,000 | |
Jan 31 2020 | RTRX | Retrophin, Inc. | Clague Laura | Chief Financial Off ... | Grant | A | 0.00 | 9,000 | 0 | 22,500 | 13.5 K to 22.5 K (+66.67 %) |
Jan 31 2020 | RTRX | Retrophin, Inc. | Dube Eric M | Chief Executive Off ... | Option Exercise | A | 0.00 | 30,000 | 0 | 30,000 | |
Jan 31 2020 | RTRX | Retrophin, Inc. | Dube Eric M | Chief Executive Off ... | Option Exercise | A | 0.00 | 35,000 | 0 | 35,000 | |
Jan 31 2020 | RTRX | Retrophin, Inc. | Dube Eric M | Chief Executive Off ... | Option Exercise | A | 15.46 | 300,000 | 4,638,000 | 300,000 | |
Jan 31 2020 | RTRX | Retrophin, Inc. | Dube Eric M | Chief Executive Off ... | Grant | A | 0.00 | 35,000 | 0 | 77,500 | 42.5 K to 77.5 K (+82.35 %) |
Jan 08 2020 | RTRX | Retrophin, Inc. | REED ELIZABETH E | SVP, GC & Corporate ... | Sell | S | 15.14 | 750 | 11,355 | 18,008 | 18.8 K to 18 K (-4.00 %) |
Jan 08 2020 | RTRX | Retrophin, Inc. | REED ELIZABETH E | SVP, GC & Corporate ... | Sell | S | 13.94 | 750 | 10,455 | 18,758 | 19.5 K to 18.8 K (-3.84 %) |
Jan 08 2020 | RTRX | Retrophin, Inc. | REED ELIZABETH E | SVP, GC & Corporate ... | Sell | S | 15.14 | 750 | 11,355 | 18,008 | 18.8 K to 18 K (-4.00 %) |
Jan 08 2020 | RTRX | Retrophin, Inc. | REED ELIZABETH E | SVP, GC & Corporate ... | Sell | S | 13.94 | 750 | 10,455 | 18,758 | 19.5 K to 18.8 K (-3.84 %) |
Jan 08 2020 | RTRX | Retrophin, Inc. | Dube Eric M | Chief Executive Off ... | Sell | S | 15.14 | 3,750 | 56,775 | 42,500 | 46.3 K to 42.5 K (-8.11 %) |
Jan 08 2020 | RTRX | Retrophin, Inc. | Dube Eric M | Chief Executive Off ... | Sell | S | 13.94 | 3,750 | 52,275 | 46,250 | 50 K to 46.3 K (-7.50 %) |
Jan 08 2020 | RTRX | Retrophin, Inc. | Dube Eric M | Chief Executive Off ... | Sell | S | 15.14 | 3,750 | 56,775 | 42,500 | 46.3 K to 42.5 K (-8.11 %) |
Jan 08 2020 | RTRX | Retrophin, Inc. | Dube Eric M | Chief Executive Off ... | Sell | S | 13.94 | 3,750 | 52,275 | 46,250 | 50 K to 46.3 K (-7.50 %) |
Nov 29 2019 | RTRX | Retrophin, Inc. | ASELAGE STEVE | Director | Sell | S | 13.91 | 5,000 | 69,553 | 250,966 | 256 K to 251 K (-1.95 %) |
Nov 29 2019 | RTRX | Retrophin, Inc. | ASELAGE STEVE | Director | Sell | S | 13.91 | 5,000 | 69,553 | 250,966 | 256 K to 251 K (-1.95 %) |
Oct 02 2019 | RTRX | Retrophin, Inc. | Heerma Peter | Chief Commercial Of ... | Option Exercise | A | 11.25 | 100,000 | 1,125,000 | 100,000 | |
Oct 02 2019 | RTRX | Retrophin, Inc. | Heerma Peter | Chief Commercial Of ... | Grant | A | 0.00 | 35,000 | 0 | 35,000 | 0 to 35 K |
Jul 31 2019 | RTRX | Retrophin, Inc. | Rosenberg Noah L. | Chief Medical Offic ... | Sell | S | 20.07 | 1,250 | 25,088 | 13,500 | 14.8 K to 13.5 K (-8.47 %) |
Jul 31 2019 | RTRX | Retrophin, Inc. | Rosenberg Noah L. | Chief Medical Offic ... | Sell | S | 20.07 | 1,250 | 25,088 | 13,500 | 14.8 K to 13.5 K (-8.47 %) |
Jul 31 2019 | RTRX | Retrophin, Inc. | Rosenberg Noah L. | Chief Medical Offic ... | Sell | S | 19.82 | 1,250 | 24,775 | 14,750 | 16 K to 14.8 K (-7.81 %) |
Jul 31 2019 | RTRX | Retrophin, Inc. | Rosenberg Noah L. | Chief Medical Offic ... | Sell | S | 19.82 | 1,250 | 24,775 | 14,750 | 16 K to 14.8 K (-7.81 %) |
May 16 2019 | RTRX | Retrophin, Inc. | McFarlane Neil F. | Chief Operating Off ... | Sell | S | 18.71 | 984 | 18,411 | 26,988 | 28 K to 27 K (-3.52 %) |
May 16 2019 | RTRX | Retrophin, Inc. | McFarlane Neil F. | Chief Operating Off ... | Sell | S | 17.78 | 984 | 17,496 | 27,972 | 29 K to 28 K (-3.40 %) |
May 16 2019 | RTRX | Retrophin, Inc. | Clague Laura | Chief Financial Off ... | Sell | S | 18.71 | 1,250 | 23,388 | 13,500 | 14.8 K to 13.5 K (-8.47 %) |
May 16 2019 | RTRX | Retrophin, Inc. | Clague Laura | Chief Financial Off ... | Sell | S | 17.78 | 1,250 | 22,225 | 14,750 | 16 K to 14.8 K (-7.81 %) |
May 16 2019 | RTRX | Retrophin, Inc. | ROTE WILLIAM E. | Senior Vice Preside ... | Sell | S | 17.76 | 812 | 14,421 | 18,185 | 19 K to 18.2 K (-4.27 %) |
May 16 2019 | RTRX | Retrophin, Inc. | ROTE WILLIAM E. | Senior Vice Preside ... | Sell | S | 17.78 | 813 | 14,455 | 18,997 | 19.8 K to 19 K (-4.10 %) |
May 16 2019 | RTRX | Retrophin, Inc. | REED ELIZABETH E | SVP, GC & Corporate ... | Sell | S | 17.71 | 525 | 9,298 | 19,508 | 20 K to 19.5 K (-2.62 %) |
May 16 2019 | RTRX | Retrophin, Inc. | REED ELIZABETH E | SVP, GC & Corporate ... | Sell | S | 17.75 | 525 | 9,319 | 20,033 | 20.6 K to 20 K (-2.55 %) |
May 16 2019 | RTRX | Retrophin, Inc. | ASELAGE STEVE | Director | Sell | S | 17.82 | 1,838 | 32,753 | 255,966 | 257.8 K to 256 K (-0.71 %) |
May 16 2019 | RTRX | Retrophin, Inc. | ASELAGE STEVE | Director | Sell | S | 17.79 | 1,838 | 32,698 | 257,804 | 259.6 K to 257.8 K (-0.71 %) |
May 15 2019 | RTRX | Retrophin, Inc. | Poole Sandra | Director | Option Exercise | A | 17.87 | 14,000 | 250,180 | 14,000 | |
May 15 2019 | RTRX | Retrophin, Inc. | Poole Sandra | Director | Grant | A | 0.00 | 3,500 | 0 | 3,500 | 0 to 3.5 K |
May 10 2019 | RTRX | Retrophin, Inc. | Squarer Ron | Director | Option Exercise | A | 17.94 | 8,000 | 143,520 | 8,000 | |
May 10 2019 | RTRX | Retrophin, Inc. | Squarer Ron | Director | Grant | A | 0.00 | 2,000 | 0 | 8,875 | 6.9 K to 8.9 K (+29.09 %) |
May 10 2019 | RTRX | Retrophin, Inc. | Orwin John A | Director | Option Exercise | A | 17.94 | 8,000 | 143,520 | 8,000 | |
May 10 2019 | RTRX | Retrophin, Inc. | Orwin John A | Director | Grant | A | 0.00 | 2,000 | 0 | 8,875 | 6.9 K to 8.9 K (+29.09 %) |
May 10 2019 | RTRX | Retrophin, Inc. | Meckler Jeffrey A | Director | Option Exercise | A | 17.94 | 8,000 | 143,520 | 8,000 | |
May 10 2019 | RTRX | Retrophin, Inc. | Meckler Jeffrey A | Director | Grant | A | 0.00 | 2,000 | 0 | 61,000 | 59 K to 61 K (+3.39 %) |
May 10 2019 | RTRX | Retrophin, Inc. | LYONS GARY A | Director | Option Exercise | A | 17.94 | 8,000 | 143,520 | 8,000 | |
May 10 2019 | RTRX | Retrophin, Inc. | LYONS GARY A | Director | Grant | A | 0.00 | 2,000 | 0 | 31,000 | 29 K to 31 K (+6.90 %) |
May 10 2019 | RTRX | Retrophin, Inc. | KOZARICH JOHN W | Director | Option Exercise | A | 17.94 | 8,000 | 143,520 | 8,000 | |
May 10 2019 | RTRX | Retrophin, Inc. | KOZARICH JOHN W | Director | Grant | A | 0.00 | 2,000 | 0 | 29,000 | 27 K to 29 K (+7.41 %) |
May 10 2019 | RTRX | Retrophin, Inc. | Coughlin Timothy P | Director | Option Exercise | A | 17.94 | 8,000 | 143,520 | 8,000 | |
May 10 2019 | RTRX | Retrophin, Inc. | Coughlin Timothy P | Director | Grant | A | 0.00 | 2,000 | 0 | 29,000 | 27 K to 29 K (+7.41 %) |
May 10 2019 | RTRX | Retrophin, Inc. | Baynes Roy D. | Director | Option Exercise | A | 17.94 | 8,000 | 143,520 | 8,000 | |
May 10 2019 | RTRX | Retrophin, Inc. | Baynes Roy D. | Director | Grant | A | 0.00 | 2,000 | 0 | 11,000 | 9 K to 11 K (+22.22 %) |
May 10 2019 | RTRX | Retrophin, Inc. | ASELAGE STEVE | Director | Option Exercise | A | 17.94 | 8,000 | 143,520 | 8,000 | |
May 10 2019 | RTRX | Retrophin, Inc. | ASELAGE STEVE | Director | Grant | A | 0.00 | 2,000 | 0 | 259,642 | 257.6 K to 259.6 K (+0.78 %) |
May 10 2019 | RTRX | Retrophin, Inc. | REED ELIZABETH E | SVP, GC & Corporate ... | Option Exercise | A | 0.00 | 6,000 | 0 | 6,000 | |
May 10 2019 | RTRX | Retrophin, Inc. | REED ELIZABETH E | SVP, GC & Corporate ... | Option Exercise | A | 0.00 | 6,000 | 0 | 6,000 | |
May 10 2019 | RTRX | Retrophin, Inc. | REED ELIZABETH E | SVP, GC & Corporate ... | Option Exercise | A | 17.96 | 40,000 | 718,400 | 40,000 | |
May 10 2019 | RTRX | Retrophin, Inc. | REED ELIZABETH E | SVP, GC & Corporate ... | Option Exercise | A | 17.96 | 40,000 | 718,400 | 40,000 | |
May 10 2019 | RTRX | Retrophin, Inc. | REED ELIZABETH E | SVP, GC & Corporate ... | Grant | A | 0.00 | 6,000 | 0 | 20,558 | 14.6 K to 20.6 K (+41.21 %) |
May 10 2019 | RTRX | Retrophin, Inc. | REED ELIZABETH E | SVP, GC & Corporate ... | Grant | A | 0.00 | 6,000 | 0 | 20,558 | 14.6 K to 20.6 K (+41.21 %) |
May 10 2019 | RTRX | Retrophin, Inc. | ROTE WILLIAM E. | Senior Vice Preside ... | Option Exercise | A | 0.00 | 6,000 | 0 | 6,000 | |
May 10 2019 | RTRX | Retrophin, Inc. | ROTE WILLIAM E. | Senior Vice Preside ... | Option Exercise | A | 0.00 | 6,000 | 0 | 6,000 | |
May 10 2019 | RTRX | Retrophin, Inc. | ROTE WILLIAM E. | Senior Vice Preside ... | Option Exercise | A | 17.96 | 40,000 | 718,400 | 40,000 | |
May 10 2019 | RTRX | Retrophin, Inc. | ROTE WILLIAM E. | Senior Vice Preside ... | Option Exercise | A | 17.96 | 40,000 | 718,400 | 40,000 | |
May 10 2019 | RTRX | Retrophin, Inc. | ROTE WILLIAM E. | Senior Vice Preside ... | Grant | A | 0.00 | 6,000 | 0 | 19,810 | 13.8 K to 19.8 K (+43.45 %) |
May 10 2019 | RTRX | Retrophin, Inc. | ROTE WILLIAM E. | Senior Vice Preside ... | Grant | A | 0.00 | 6,000 | 0 | 19,810 | 13.8 K to 19.8 K (+43.45 %) |
May 10 2019 | RTRX | Retrophin, Inc. | Rosenberg Noah L. | Chief Medical Offic ... | Option Exercise | A | 0.00 | 6,000 | 0 | 6,000 | |
May 10 2019 | RTRX | Retrophin, Inc. | Rosenberg Noah L. | Chief Medical Offic ... | Option Exercise | A | 0.00 | 6,000 | 0 | 6,000 | |
May 10 2019 | RTRX | Retrophin, Inc. | Rosenberg Noah L. | Chief Medical Offic ... | Option Exercise | A | 17.96 | 40,000 | 718,400 | 40,000 | |
May 10 2019 | RTRX | Retrophin, Inc. | Rosenberg Noah L. | Chief Medical Offic ... | Option Exercise | A | 17.96 | 40,000 | 718,400 | 40,000 | |
May 10 2019 | RTRX | Retrophin, Inc. | Rosenberg Noah L. | Chief Medical Offic ... | Grant | A | 0.00 | 6,000 | 0 | 16,000 | 10 K to 16 K (+60.00 %) |
May 10 2019 | RTRX | Retrophin, Inc. | Rosenberg Noah L. | Chief Medical Offic ... | Grant | A | 0.00 | 6,000 | 0 | 16,000 | 10 K to 16 K (+60.00 %) |
May 10 2019 | RTRX | Retrophin, Inc. | Clague Laura | Chief Financial Off ... | Option Exercise | A | 0.00 | 6,000 | 0 | 6,000 | |
May 10 2019 | RTRX | Retrophin, Inc. | Clague Laura | Chief Financial Off ... | Option Exercise | A | 0.00 | 6,000 | 0 | 6,000 | |
May 10 2019 | RTRX | Retrophin, Inc. | Clague Laura | Chief Financial Off ... | Option Exercise | A | 17.96 | 40,000 | 718,400 | 40,000 | |
May 10 2019 | RTRX | Retrophin, Inc. | Clague Laura | Chief Financial Off ... | Option Exercise | A | 17.96 | 40,000 | 718,400 | 40,000 | |
May 10 2019 | RTRX | Retrophin, Inc. | Clague Laura | Chief Financial Off ... | Grant | A | 0.00 | 6,000 | 0 | 16,000 | 10 K to 16 K (+60.00 %) |
May 10 2019 | RTRX | Retrophin, Inc. | Clague Laura | Chief Financial Off ... | Grant | A | 0.00 | 6,000 | 0 | 16,000 | 10 K to 16 K (+60.00 %) |
May 10 2019 | RTRX | Retrophin, Inc. | Dube Eric M | Chief Executive Off ... | Option Exercise | A | 0.00 | 6,000 | 0 | 6,000 | |
May 10 2019 | RTRX | Retrophin, Inc. | Dube Eric M | Chief Executive Off ... | Option Exercise | A | 0.00 | 6,000 | 0 | 6,000 | |
Feb 20 2019 | RTRX | Retrophin, Inc. | ROTE WILLIAM E. | Senior Vice Preside ... | Sell | S | 21.52 | 1,250 | 26,900 | 13,810 | 15.1 K to 13.8 K (-8.30 %) |
Feb 20 2019 | RTRX | Retrophin, Inc. | ROTE WILLIAM E. | Senior Vice Preside ... | Sell | S | 21.44 | 1,250 | 26,800 | 15,060 | 16.3 K to 15.1 K (-7.66 %) |
Feb 13 2019 | RTRX | Retrophin, Inc. | REED ELIZABETH E | SVP, GC & Corporate ... | Sell | S | 21.50 | 884 | 19,006 | 14,558 | 15.4 K to 14.6 K (-5.72 %) |
Feb 13 2019 | RTRX | Retrophin, Inc. | REED ELIZABETH E | SVP, GC & Corporate ... | Sell | S | 21.38 | 885 | 18,921 | 15,442 | 16.3 K to 15.4 K (-5.42 %) |
Feb 13 2019 | RTRX | Retrophin, Inc. | ROTE WILLIAM E. | Senior Vice Preside ... | Sell | S | 21.50 | 992 | 21,328 | 16,007 | 17 K to 16 K (-5.84 %) |
Feb 13 2019 | RTRX | Retrophin, Inc. | ROTE WILLIAM E. | Senior Vice Preside ... | Sell | S | 21.38 | 993 | 21,230 | 16,999 | 18 K to 17 K (-5.52 %) |
Feb 13 2019 | RTRX | Retrophin, Inc. | Clague Laura | Chief Financial Off ... | Sell | S | 21.50 | 1,016 | 21,844 | 10,000 | 11 K to 10 K (-9.22 %) |
Feb 13 2019 | RTRX | Retrophin, Inc. | Clague Laura | Chief Financial Off ... | Sell | S | 21.38 | 1,017 | 21,743 | 11,016 | 12 K to 11 K (-8.45 %) |
Feb 13 2019 | RTRX | Retrophin, Inc. | ASELAGE STEVE | Chief Executive Off ... | Sell | S | 21.50 | 1,065 | 22,898 | 257,642 | 258.7 K to 257.6 K (-0.41 %) |
Feb 13 2019 | RTRX | Retrophin, Inc. | ASELAGE STEVE | Chief Executive Off ... | Sell | S | 21.38 | 1,065 | 22,770 | 258,707 | 259.8 K to 258.7 K (-0.41 %) |
Jan 09 2019 | RTRX | Retrophin, Inc. | REED ELIZABETH E | SVP, GC & Corporate ... | Sell | S | 23.82 | 750 | 17,865 | 16,327 | 17.1 K to 16.3 K (-4.39 %) |
Jan 09 2019 | RTRX | Retrophin, Inc. | REED ELIZABETH E | SVP, GC & Corporate ... | Sell | S | 24.09 | 750 | 18,068 | 17,077 | 17.8 K to 17.1 K (-4.21 %) |
Jan 08 2019 | RTRX | Retrophin, Inc. | Dube Eric M | Chief Executive Off ... | Option Exercise | A | 0.00 | 50,000 | 0 | 50,000 | |
Jan 08 2019 | RTRX | Retrophin, Inc. | Dube Eric M | Chief Executive Off ... | Option Exercise | A | 23.34 | 400,000 | 9,336,000 | 400,000 | |
Jan 08 2019 | RTRX | Retrophin, Inc. | Dube Eric M | Chief Executive Off ... | Grant | A | 0.00 | 50,000 | 0 | 50,000 | 0 to 50 K |
Dec 21 2018 | RTRX | Retrophin, Inc. | McFarlane Neil F. | Chief Operating Off ... | Sell | S | 22.56 | 6,404 | 144,452 | 28,956 | 35.4 K to 29 K (-18.11 %) |
Dec 21 2018 | RTRX | Retrophin, Inc. | McFarlane Neil F. | Chief Operating Off ... | Sell | S | 22.00 | 4,721 | 103,881 | 35,360 | 40.1 K to 35.4 K (-11.78 %) |
Dec 21 2018 | RTRX | Retrophin, Inc. | ASELAGE STEVE | Chief Executive Off ... | Sell | S | 22.35 | 900 | 20,111 | 259,772 | 260.7 K to 259.8 K (-0.35 %) |
Dec 21 2018 | RTRX | Retrophin, Inc. | ASELAGE STEVE | Chief Executive Off ... | Sell | S | 21.69 | 5,288 | 114,718 | 260,672 | 266 K to 260.7 K (-1.99 %) |
Dec 21 2018 | RTRX | Retrophin, Inc. | ASELAGE STEVE | Chief Executive Off ... | Sell | S | 21.97 | 6,188 | 135,958 | 265,960 | 272.1 K to 266 K (-2.27 %) |
Dec 21 2018 | RTRX | Retrophin, Inc. | Clague Laura | Chief Financial Off ... | Sell | S | 22.34 | 900 | 20,109 | 12,033 | 12.9 K to 12 K (-6.96 %) |
Dec 21 2018 | RTRX | Retrophin, Inc. | Clague Laura | Chief Financial Off ... | Sell | S | 21.67 | 2,850 | 61,751 | 12,933 | 15.8 K to 12.9 K (-18.06 %) |